MBOAT2 and permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome: The peak expression of the four genes—MBOAT2, CDA, LPCAT2 and B4GALT5—is where we may use this data to improve the impact of anticancer medications on PACA patients.